Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.1M Buy
249,796
+64,403
+35% +$3.79M ﹤0.01% 2856
2026
Q1
$9.58M Sell
185,393
-27,785
-13% -$2.15M ﹤0.01% 3403
2025
Q4
$18.2M Sell
213,178
-147,278
-41% -$12.7M ﹤0.01% 2672
2025
Q3
$21.3M Buy
360,456
+126,738
+54% +$4.84M ﹤0.01% 2493
2025
Q2
$12M Buy
233,718
+92,563
+66% +$3.35M ﹤0.01% 2892
2025
Q1
$3.61M Sell
141,155
-86,563
-38% -$2.67M ﹤0.01% 4126
2024
Q4
$4.06M Buy
227,718
+185,578
+440% +$3.02M ﹤0.01% 4056
2024
Q3
$580K Sell
42,140
-10,676
-20% -$162K ﹤0.01% 5112
2024
Q2
$812K Buy
+52,816
New +$857K ﹤0.01% 4605

Other funds holding GRAL

UBS Group's GRAL Position: Q2 2026 in Review

UBS Group increased its GRAIL Inc (GRAL) stake by 35% in Q2 2026, buying an estimated $3.79M and bringing the position to 249,796 shares worth $17.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2856.

UBS Group first reported a position in GRAL in Q2 2024 and has held it in 9 quarters since. The position peaked at $21.3M in Q3 2025. 373 funds tracked by Wall St. Rank hold GRAL as of Q2 2026.

  • UBS Group held 249,796 shares of GRAIL Inc worth $17.1M as of Q2 2026.
  • UBS Group bought 64,403 GRAIL Inc shares in Q2 2026, an estimated $3.79M.
  • GRAIL Inc made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #2856 holding.
  • UBS Group first reported a position in GRAIL Inc in Q2 2024 and has held it in 9 quarters since.
  • UBS Group's GRAIL Inc position peaked at $21.3M in Q3 2025.
  • 373 funds tracked by Wall St. Rank held GRAIL Inc as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.